Indaptus Therapeutics Inc's (NYSE:INDP) short interest as a percent of float has risen 26.44% since its last report. According to exchange reported data, there are now 17 thousand shares sold short, which is 1.1% of all regular shares that are available for trading. Based on its trading volume, i... Read more
Benzinga - Dec 25
Amicus Therapeutics Inc's (NYSE:FOLD) short interest as a percent of float has risen 7.13% since its last report. According to exchange reported data, there are now 19.31 million shares sold short, which is 6.31% of all regular shares that are available for trading. Based on its trading volume, i... Read more
Benzinga - Dec 24
Here’s what we’re watching in chemistry business news this week Read more
Chemical & Engineering News - Dec 09
Investors with a lot of money to spend have taken a bullish stance on Structure Therapeutics (NASDAQ:GPCR).And retail traders should know.We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.Whether these are institutions or just wea... Read more
Benzinga - Dec 09
ADC Therapeutics SA (NYSE:ADCT) is facing a sharp market reaction as investors digest the latest trial results for its cancer drug, Zynlonta.ADCT is feeling the pressure from bearish momentum. View the charts here.Despite promising efficacy data from the ongoing LOTIS-7 trial, including high resp... Read more
Benzinga - Dec 03
Whales with a lot of money to spend have taken a noticeably bullish stance on Capricor Therapeutics.Looking at options history for Capricor Therapeutics (NASDAQ:CAPR) we detected 13 trades.If we consider the specifics of each trade, it is accurate to state that 61% of the investors opened trades ... Read more
Benzinga - Nov 24
Quince Therapeutics, Inc. (NASDAQ:QNCX – Free Report) – Equities research analysts at Brookline Capital Management dropped their FY2028 earnings per share estimates for shares of Quince Therapeutics in a research note issued on Thursday, November 13th. Brookline Capital Management analyst K. Raja... Read more
Americanbankingnews - Nov 19
Leap Therapeutics (NASDAQ:LPTX – Get Free Report) and ObsEva (NASDAQ:OBSV – Get Free Report) are both small-cap manufacturing companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional... Read more
The Lincolnian Online - Nov 17
PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) reported third quarter 2025 results and announced a major expansion of its pipeline with a new induced pluripotent stem cell (iPSC)-derived beta ... Read more
Mychesco - Nov 17
According to DataM Intelligence has published a new research report on "Asthma and COPD Drug Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Read more
Openpr.com - Nov 17
